NEW YORK — A scheduled hearing for Luigi Mangione, accused of murdering UnitedHealthcare CEO Brian Thompson, was postponed on Tuesday due to a failure by prosecutors to inform jail officials that he was needed in court. The hearing, which was set to take place in front of Judge Gregory Carro, was delayed shortly after its intended start time.
Assistant District Attorney Joel Seidemann acknowledged the oversight, stating, "It’s on us. We got the writ signed but we failed to serve it." Although a federal judge had previously authorized Mangione to appear in a suit, this did not suffice to ensure his transport to the hearing.
Mangione, 28, is currently detained at a federal facility in Brooklyn as he awaits trial on both state and federal charges related to the December 4, 2024, incident. He has pleaded not guilty in both cases, facing the possibility of life imprisonment if convicted.
Judge Carro was expected to make a ruling on an undisclosed matter during Tuesday's hearing, following a secret proceeding held two weeks prior, which was sealed at the defense's request.
The next hearing is now scheduled for Wednesday, where Carro may deliver his decision. Mangione’s state trial is set to commence on September 8, while his federal trial concerning stalking charges is slated for October 13.
Thompson, 50, was fatally shot as he walked to a hotel for an investor conference in Manhattan. Surveillance footage indicated that he was attacked from behind by a masked assailant. Police have noted that the ammunition used bore phrases like "delay," "deny," and "depose," echoing tactics often attributed to insurance companies.
Following the murder, Mangione was apprehended five days later at a McDonald's in Altoona, Pennsylvania, about 230 miles from the crime scene. A previous ruling by Judge Carro allowed the introduction of a gun and a notebook as evidence against Mangione, with the gun being a 3D-printed model that matched the weapon used in Thompson's killing. The notebook reportedly contained writings expressing a desire to target health insurance executives.
Reported by HarborBeat based on The Baltimore Banner (source).
0 Comments
Log in to join the conversation.